Trial · NCT01580163
Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification
NCT01580163, Not applicable, Completed, Shanghai Mental Health Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification. Trials, record NCT01580163. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01580163
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification
- NCT number
- NCT01580163
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 554 participants, actual
- Lead sponsor
- Shanghai Mental Health Center
- Conditions
- Heroin Addiction
- Interventions
- JITAI Combined with psychological intervention, Methadone, Traditional Chinese Medicine JITAI
- First posted
- 2012-04-18
- Last updated
- 2015-11-18
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The drug use pattern during observation period | Baseline ,26 weeks and 52 weeks | The investigator will ues NHI(Nature History Interview) to describe the drug use pattern and and compare the different change among different groups during observation period |
| Secondary | The change of ASI(Addiction Severity Index) after the treatment and observation | Baseline,26weeks and 52 weeks | The investigator will use ASI to describe the addiction severity of objects and compare the different change among different groups during observation period. |
| Secondary | the change of drug use pattern during observation period | Baseline,26weeks and 52 weeks | The investigator will ues NHI(Nature History Interview) to describe the drug use pattern and and compare the different change among different groups during observation period. |
| Secondary | the change of SF-36(the MOS item short form health survey) after treatment and observation | Baseline,26 weeks and 52 weeks | The investigator will use SF-36 to describe the health status of objects and compare the different change among different groups during observation period. |
| Secondary | the change of SAS(Self-Rating Anxiety Scale) and SDS(Self-rating Depression Scale) during observation period | Baseline ,26weeks and 52 weeks | The investigator will use SAS and SDS to describe the anxiety status and depression status then compare the different change among different groups during observation period. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01580163
GET https://conductscience.org/api/trials/v1/NCT01580163/registered